Please ensure Javascript is enabled for purposes of website accessibility
Home > Featured Products > Bacteria & Viruses-related products > Canine Parvovirus Type 2 (CPV-2)

Detect and characterize Canine Parvovirus Type 2 (CPV-2) — a highly contagious DNA virus causing severe hemorrhagic gastroenteritis in dogs with high mortality in unvaccinated puppies. Our reagents target the VP2 capsid protein (the primary neutralizing epitope and vaccine antigen) and NS1 (non-structural protein for replication detection), with monoclonal antibodies validated for rapid immunochromatographic testing (GICA) and immunofluorescence (IFA), recombinant clones with neutralization and blocking activity, and a reference-grade biosimilar antibody. RUO

Rapid Diagnostic Monoclonal AntibodiesClones 1A420 and 1A421 validated for GICA (gold immunochromatographic assay) — suitable for rapid point-of-care CPV antigen test development. Clones 1A422 and 1A423 validated for IFA (immunofluorescence assay) for laboratory confirmation of CPV infection in tissue and cell culture samples.
Neutralizing & Blocking AntibodiesRecombinant clone Mab14 with validated neutralization activity against CPV capsid. Clone 3D10 targeting VP2 with validated blocking activity for competitive ELISA development. CPV2/FPV cross-reactive VP1 clones (SAA0842, SAA0843, SAA2338) for parvovirus cross-species studies.
Reference Antibody (Anivovetmab, RUO)Research-grade biosimilar of Anivovetmab (anti-CPV VP2), validated for ELISA and FACS. Suitable as a positive control and reference standard for anti-CPV antibody potency assays and vaccine immunogenicity studies.
Recombinant Proteins & Polyclonal AntibodiesHis-tagged VP2 and NS1 recombinant proteins with matched polyclonal antibodies. VP2 protein validated for SDS-PAGE, WB, ELISA, and as immunogen. NS1 polyclonal antibody validated for WB, IHC, and ELISA — enabling detection of viral replication alongside structural capsid antigen.

All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.

References

1. Decaro N, Buonavoglia C. Canine parvovirus — a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol. 2012;155(1):1-12. DOI

2. Cotmore SF, Agbandje-McKenna M, Canuti M, et al. ICTV virus taxonomy profile: Parvoviridae. J Gen Virol. 2019;100(3):367-368. DOI

9 product results for "Canine Parvovirus Type 2 (CPV-2)"

Options+
Options
Confirm
  • Product types
    0 selected
    Proteins (2)
    Antibodies (6)
    Research Biosimilar (1)
  • Expression system
    0 selected
    E. coli (2)
    Mammalian Cells (1)
  • Target
    0 selected
    Capsid (1)
    Capsid protein VP1 (2)
    NS1 (1)
    VP1 (1)
    Capsid protein VP2 (3)
  • Species
    0 selected
    Canine parvovirus type 2 (CPV-2) (3)
  • Applications
    0 selected
    SDS-PAGE (2)
    Blocking (1)
    WB (3)
    IHC (1)
    Bioactivity testing in progress (1)
    ELISA (8)
    Bioactivity: FACS (1)
    Neutralization (1)
    Functional assay (1)
    Immunogen (2)
    Research in vivo (1)
  • Reactivity
    0 selected
    Mink enteritis virus (1)
    Murine minute virus (1)
    Feline panleukopenia virus (FPV) (3)
    LuIII virus (1)
    Canine parvovirustype 2 (CPV-2) (1)
    Canine parvovirus type 2 (CPV-2) (4)
    Canine parvovirus (1)
    Feline panleukopenia (1)
  • Host species
    0 selected
    Mouse (4)
    Dog (1)
    Caninized (1)
    Rabbit (1)
  • Clonality
    0 selected
    Monoclonal (6)
    Polyclonal (1)
  • Conjugate
    0 selected
    Unconjugated (7)